Affimed NV

Company Profile

Affimed NV had its IPO on 2014-09-12 under the ticker symbol AFMD.

The company operates in the Healthcare sector and Biotechnology industry. Affimed NV has a staff strength of 197 employees.

Stock update

Shares of Affimed NV opened at $0.78 at the start of the last trading session i.e. 2023-03-19.

The stocks traded within a range of $0.74 - $0.82, and closed at $0.76.

This is a -1.94% slip from the previous day's closing price.

A total volume of 977,700 shares were traded at the close of the day’s session.

In the last one week, shares of Affimed NV have slipped by -11.32%.

Affimed NV's Key Ratios

Affimed NV has a market cap of $130.10 million, indicating a price to book ratio of 0.9232 and a price to sales ratio of 3.7958.

In the last 12-months Affimed NV’s revenue was $41.90 million with a gross profit of $41.80 million and an EBITDA of $-81228000. The EBITDA ratio measures Affimed NV's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Affimed NV’s operating margin was -195.84% while its return on assets stood at -22.46% with a return of equity of -48.04%.

In Q3, Affimed NV’s quarterly earnings growth was a positive 0% while revenue growth was a positive 68.7%.

Affimed NV’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-0.64 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Affimed NV’s profitability.

Affimed NV stock is trading at a EV to sales ratio of 2.1985 and a EV to EBITDA ratio of 0.5331. Its price to sales ratio in the trailing 12-months stood at 3.7958.

Affimed NV stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$236.40 million

Total Liabilities

$40.83 million

Operating Cash Flow

$2.16 million

Capital Expenditure

$99000

Dividend Payout Ratio

0%

Affimed NV ended 2023 with $236.40 million in total assets and $0 in total liabilities. Its intangible assets were valued at $236.40 million while shareholder equity stood at $181.10 million.

Affimed NV ended 2023 with $0 in deferred long-term liabilities, $40.83 million in other current liabilities, 1493000.00 in common stock, $-392826000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $222.90 million and cash and short-term investments were $222.90 million. The company’s total short-term debt was $5,498,000 while long-term debt stood at $13.03 million.

Affimed NV’s total current assets stands at $230.55 million while long-term investments were $0.00 and short-term investments were $0. Its net receivables were $1.69 million compared to accounts payable of $15.08 million and inventory worth $673000.00.

In 2023, Affimed NV's operating cash flow was $2.16 million while its capital expenditure stood at $99000.

Comparatively, Affimed NV paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$0.76

52-Week High

$5.1

52-Week Low

$0.818

Analyst Target Price

$7.56

Affimed NV stock is currently trading at $0.76 per share. It touched a 52-week high of $5.1 and a 52-week low of $5.1. Analysts tracking the stock have a 12-month average target price of $7.56.

Its 50-day moving average was $1.04 and 200-day moving average was $2 The short ratio stood at 2.25 indicating a short percent outstanding of 0%.

Around 360.3% of the company’s stock are held by insiders while 6380.6% are held by institutions.